Becton, Dickinson & Co (NYSE:BDX) on 07/22/2019 declared a dividend of $ 0.7700 per share payable on September 30, 2019 to shareholders of record as of September 09, 2019.

Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 1.2278742790% and has increased its dividends for 7 successive years.

Becton, Dickinson & Co's market cap is $ 67,659,574,880 and has a PE ratio of 75.10. The stock price closed yesterday at $ 250.84 and has a 52 week low/high of $ 208.62 and $ 265.87.

Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s has three segments: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical specialty products.

For more information on Becton, Dickinson & Co click here.